Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
South Tyneside Council say despite its financial pressures, it is committed to regeneration, economic growth and job creation in the borough
As Storm Doris moves away - temperatures will fall.
The Sunderland Strategic Transport Corridor (SSTC) Phase 3 is the next stage in providing a continuous dual carriageway.